Infections Staphylococcal Infections
Life Science Analytics, March 2008, Pages: 71
"Infections Staphylococcal Infections " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each ’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Staphylococcal Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Top Companies in late stage Staphylococcal Infections Projects
--AstraZeneca Plc
--Inhibitex Inc
--Intercell AG
--Merck & Co Inc
--Nabi Biopharmaceuticals
--Novartis AG
--WOCKHARDT LIMITED
--Top Companies in early stage Staphylococcal Infections Projects
--aRigen Pharmaceuticals, Inc.
--Affinium Pharmaceuticals, Inc.
--AstraZeneca Plc
--Arpida Ltd.
--Cytogenix Inc
--CrystalGenomics, Inc.
--ImmuPharma plc
--EluSys Therapeutics, Inc.
--Intercell AG
--Inhibitex Inc
--Janus Pharmaceuticals Inc
--INTRACEL Corp
--NanoBio Corporation
--Nabi Biopharmaceuticals
--Optimer Pharmaceuticals, Inc.
--Nymox Pharmaceutical Corporation
--Prolysis Limited
--Pfizer Inc
--Wyeth
--Syntopix Group plc
Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
